Thrombolysis Articles & Analysis
4 news found
The company also reported positive results from a propensity-matched comparison of patients treated in the CLOUT registry versus patients treated with pharmacomechanical thrombolysis in ATTRACT, an NIH-sponsored randomized controlled trial. Both data sets were presented during a late breaking clinical trial session at the VEINS conference in Las Vegas, NV. ...
Third, also to be presented at VEINS, is a propensity-matched comparison of patients treated in the CLOUT registry versus patients treated with pharmacomechanical thrombolysis from ATTRACT, an NIH-sponsored randomized controlled trial (RCT). ...
The primary safety outcome was major bleeding according to the Thrombolysis in Myocardial Infarction (TIMI) classification. About PAD Cardiovascular diseases (CVD), including coronary artery disease (CAD) and peripheral artery disease (PAD), account for around 1 in every 3 deaths worldwide. ...
ByBayer AG
This meta-analysis uses individual patient data from 7 different randomized controlled trials, including the CLOTBUST-ER trial, to show that “Sonothrombolysis was associated with a nearly 2-fold increase in the odds of complete recanalization compared with intravenous thrombolysis alone in patients with AIS with large vessel ...